Yayın:
Validation of a Reversed‐Phase HPLC Method for the Analysis of Sildenafil Citrate in Pharmaceutical Preparations and in Spiked Human Plasma

dc.contributor.authorERGUN, BÜLENT
dc.contributor.authorAtkoşar, Zeki
dc.contributor.authorSaraçoğlu, Ahmet
dc.contributor.authorILGIN, SİNEM
dc.contributor.authorKırcalı, Kevser
dc.contributor.authorAltıokka, Göksel
dc.contributor.orcid0000-0002-3646-7935
dc.contributor.orcid0000-0001-7331-1975
dc.date.accessioned2025-11-13T11:21:56Z
dc.date.issued2005-06-01
dc.identifier.doihttps://doi.org/10.1081/jlc-200058345
dc.identifier.endpage1548
dc.identifier.issn1082-6076
dc.identifier.issue10
dc.identifier.openalexW2148666967
dc.identifier.startpage1539
dc.identifier.urihttps://hdl.handle.net/11421/6558
dc.identifier.urihttps://doi.org/10.1081/jlc-200058345
dc.identifier.volume28
dc.language.isoen
dc.relation.ispartofJournal of Liquid Chromatography & Related Technologies
dc.rightsrestrictedAccess
dc.subjectChemistry
dc.subjectPharmacy
dc.subjectChromatography
dc.subjectSildenafil
dc.subjectHigh-performance liquid chromatography
dc.subjectMedicine
dc.subjectFamily medicine
dc.subjectInternal medicine
dc.subject.sdg6
dc.titleValidation of a Reversed‐Phase HPLC Method for the Analysis of Sildenafil Citrate in Pharmaceutical Preparations and in Spiked Human Plasma
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5053426825
local.authorid.openalexA5006654353
local.authorid.openalexA5006696390
local.authorid.openalexA5065693367
local.authorid.openalexA5067460560
local.authorid.openalexA5073338213

Dosyalar

Koleksiyonlar